Roche advances skin cancer trials as part of combination therapy strategy

ZURICH (Reuters) - Roche is pressing ahead with two skin cancer trials that combine its immunotherapy Tecentriq with other drugs after early data showed the treatments were well-tolerated and effectiv…
Read the full story: Reuters: Health News